Paul Drury

11.6k total citations · 1 hit paper
88 papers, 5.5k citations indexed

About

Paul Drury is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Nephrology. According to data from OpenAlex, Paul Drury has authored 88 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Endocrinology, Diabetes and Metabolism, 25 papers in Cardiology and Cardiovascular Medicine and 15 papers in Nephrology. Recurrent topics in Paul Drury's work include Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers), Blood Pressure and Hypertension Studies (14 papers) and Diabetes Treatment and Management (12 papers). Paul Drury is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers), Blood Pressure and Hypertension Studies (14 papers) and Diabetes Treatment and Management (12 papers). Paul Drury collaborates with scholars based in United Kingdom, New Zealand and United States. Paul Drury's co-authors include Timothy M. E. Davis, Paul Glasziou, R. John Simes, James D. Best, Marja‐Riitta Taskinen, Russell Scott, David Sullivan, Michael C dʼEmden, Markku Laakso and Peter G. Colman and has published in prestigious journals such as The Lancet, Circulation and Annals of Internal Medicine.

In The Last Decade

Paul Drury

88 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

2005 2.4k citations Russell Scott, Marja‐Riitta Taskinen et al. The Lancet profile →

Peers

Countries citing papers authored by Paul Drury

Since Specialization

Citations

This map shows the geographic impact of Paul Drury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Drury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Drury more than expected).

Fields of papers citing papers by Paul Drury

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Drury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Drury. The network helps show where Paul Drury may publish in the future.

Co-authorship network of co-authors of Paul Drury

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Drury. A scholar is included among the top collaborators of Paul Drury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Drury. Paul Drury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Factors associated with fragility fractures in type 2 diabetes: An analysis of the randomised controlled Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study 2023 ·Diabetes/Metabolism Research and Reviews ·Angela Sheu, Rachel O’Connell, Alicia J. Jenkins, Thach Tran, Paul Drury, David Sullivan, (unknown), Peter G. Colman, Richard O’Brien, Y. Antero Kesäniemi, Chris White, Anthony Keech	7
2	Cardiovascular risk prediction in type 2 diabetes before and after widespread screening: a derivation and validation study 2021 ·The Lancet ·Romana Pylypchuk, Sue Wells, Andrew Kerr, Katrina Poppe, Matire Harwood, Suneela Mehta, Corina Grey, Billy Wu, Vanessa Selak, Paul Drury, Wing C. Chan, Brandon Orr‐Walker, Rinki Murphy, Jim Mann, Jeremy Krebs, Jinfeng Zhao, Rod Jackson	33
3	Can administrative health utilisation data provide an accurate diabetes prevalence estimate for a geographical region? 2018 ·Diabetes Research and Clinical Practice ·Wing C. Chan, (unknown), Mildred Lee, (unknown), (unknown), Paul Drury, Martin Tobias	13
4	The future of population registers: linking routine health datasets to assess a population's current glycaemic status for quality improvement 2014 ·BMJ Open ·Wing C. Chan, Gary Jackson, Craig Wright, Brandon Orr‐Walker, Paul Drury, (unknown), (unknown), (unknown), Rod Jackson	11
5	Understanding the new HbA1c units for the diagnosis of Type 2 diabetes. 2012 ·PubMed ·G. D. Braatvedt, Tim Cundy, Michael Crooke, Chris Florkowski, Jim Mann, Helen Lunt, Rod Jackson, Brandon Orr‐Walker, Timothy Kenealy, Paul Drury	36
6	Abstract 18987: Fenofibrate Reduces Peripheral Neuropathy in Type 2 Diabetes: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study 2010 ·Circulation ·Kushwin Rajamani, Mark W. Donoghoe, Liping Li, (unknown), Peter G. Colman, Paul Drury, Markku Laakso, Anthony Keech	2
7	Protection against nephropathy with fenofibrate in type 2 diabetes mellitus: the FIELD study 2009 ·Circulation ·Anthony Keech, Paul Drury, Timothy M. E. Davis, Mark W. Donoghoe, Markku Laakso, Malcolm J. Whiting, Russell Scott, Michael C dʼEmden	7
8	Abstract 1040: Lower-Limb Amputation in Patients With Type 2 Diabetes Mellitus: Factors Predicting Risk in the FIELD Study 2009 ·Circulation ·Kushwin Rajamani, Liping Li, Y. Antero Kesäniemi, Merryn Voysey, David Hunt, Paul Drury, Michael C dʼEmden, Peter G. Colman, Marja‐Riitta Taskinen, Anthony Keech	1
9	Impact of Achieved Blood Pressure on Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial 2005 ·Journal of the American Society of Nephrology ·Tomás Berl, Lawrence G. Hunsicker, Julia B. Lewis, Marc A. Pfeffer, Jerome G. Porush, Jean‐Lucien Rouleau, Paul Drury, Enric Esmatjes, Donald E. Hricik, Marc A. Pohl, Itamar Raz, Philippe Vanhille, Thomas Wiegmann, Bernard M. Wolfe, Francesco Locatelli, Samuel Z. Goldhaber, Edmund J. Lewis	223
10	Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: A case for albuminuria 2004 ·Kidney International ·Nagesh S. Anavekar, Daniel J. Gans, Tomás Berl, Richard D. Rohde, William A. Cooper, Amitabha Bhaumik, Lawrence G. Hunsicker, Jean‐Lucien Rouleau, Julia B. Lewis, Clive Rosendorff, Jerome G. Porush, Paul Drury, Enric Esmatjes, Itamar Raz, (unknown), (unknown), Samuel Z. Goldhaber, Edmund J. Lewis, Marc A. Pfeffer	93
11	An Updated Review of its Clinical Efficacy in the Management of Dyslipidaemia 2002 ·Paul Drury, Guido Franceschini, Jan Malík, Vojtěch Melenovský, Vincenzo Pasceri	6
12	Erythromycin induces supranormal gall bladder contraction in diabetic autonomic neuropathy. 1993 ·Gut ·S M Catnach, Anne Ballinger, M. J. Stevens, P D Fairclough, Richard C. Trembath, Paul Drury, P.J. Watkins	24
13	Diabetic renal disease and its prevention 1993 ·Clinical Endocrinology ·Paul Drury, Peter Watkins	2
14	Doppler velocimetry and fetal heart rate studies in nephropathic diabetics 1992 ·American Journal of Obstetrics and Gynecology ·Douglas R. Salvesen, (unknown), J. M. Brudenell, Paul Drury, K. H. Nicolaides	11
15	Regression of Left Ventricular Hypertrophy with 1 Year of Antihypertensive Treatment in Type 1 Diabetic Patients with Early Nephropathy 1991 ·Diabetic Medicine ·Mike Sampson, John B. Chambers, David Sprigings, Paul Drury	7
16	Development of Nephropathy in Diabetic Patients with a Single Kidney 1990 ·Diabetic Medicine ·Mike Sampson, Paul Drury	14
17	Intraventricular Septal Hypertrophy in Type 1 Diabetic Patients with Microalbuminuria or Early Proteinuria 1990 ·Diabetic Medicine ·Mike Sampson, John B. Chambers, David Sprigings, Paul Drury	21
18	Opioid peptides do not modulate atrial natriuretic peptide or aldosterone release under basal conditions in man 1988 ·Journal of Endocrinology ·(unknown), J. V. Anderson, C. Volta, Les Perry, Paul Drury, Stephen R. Bloom, G. M. Besser, A. Grossman	3
19	Effect of Posture on the Circadian Rhythm of Urine Flow and Electrolyte Excretion in Elderly Female Patients 1985 ·Clinical Science ·(unknown), Mary Bliss, (unknown), J. M. Thomas, Paul Drury	2
20	The determination of thiomalate in physiological fluids by high-performance liquid chromatography and electrochemical detection 1983 ·Journal of Pharmaceutical and Biomedical Analysis ·S R Rudge, David I. Perrett, Paul Drury, A J Swannell	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact